insights_auto
Why is LLY80 down 2,97%?
Dive Deeperchevron_right
LLY80:BKK
Eli Lilly And Company KTB DR
฿1,96
arrow_downward
-2,97%(-0,060) 1D
9 ຕ.ລ., 14 ໂມງ 21 ນາທີ 01 ວິນາທີ GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY80...
Open
฿1,96
High
฿2,02
Low
฿1,90
Mkt. cap
1,10 ລ້ານລ້ານ
Avg. vol.
5,07 ລ້ານ
Volume
9,67 ລ້ານ
52-wk high
฿2,12
52-wk low
฿1,27
Shares outstanding
941,36 ລ້ານ
No. of employees
50 ພັນ
Open
฿1,96
High
฿2,02
Low
฿1,90
Mkt. cap
1,10 ລ້ານລ້ານ
Avg. vol.
5,07 ລ້ານ
Volume
9,67 ລ້ານ
52-wk high
฿2,12
52-wk low
฿1,27
Shares outstanding
941,36 ລ້ານ
No. of employees
50 ພັນ
News stories
From web sources and news partners
The Motley Fool
·
15 ຊົ່ວໂມງກ່ອນ
Eli Lilly's Obesity Business Could Become a Much Bigger Healthcare Platform
Benzinga
·
16 ຊົ່ວໂມງກ່ອນ
Transcript: Eli Lilly Q2 2026 Earnings Conference Call
The Globe and Mail
·
18 ຊົ່ວໂມງກ່ອນ
How Is Eli Lilly's Oncology Portfolio Poised Ahead of Q3 Earnings?
Investing.com
·
19 ຊົ່ວໂມງກ່ອນ
Cantor Fitzgerald raises Eli Lilly stock price target on demand trends
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company KTB DR
CEODavid A. Ricks
Employees50 ພັນ
Founded1876
Headquartersອິນເດຍນາໂພລິສ, ອິນເດຍນາ, ສະຫະລັດ
SectorPharmaceutical industry
Websitelilly.com